About: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
value	Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
Subject	Monoclonal antibodies Medical physics Animal anatomy Radiation health effects Radioactivity Breakthrough therapy Experimental cancer drugs Radiation therapy Radiobiology Good practice AstraZeneca brands
part of	Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial
is hasSource of	covid:ann/target/cb8ac410ef1d4edd86950c39bace3ec7fa392665 covid:ann/target/de736d375ca9751eafc41a839b214ec8dd2a74c4 covid:ann/target/f5a4f6ba9bcde362ebe11e5ddca10b2767e33bfb covid:ann/target/6b86fc03c44a537e49b6066d4a754dc16bf94d4c covid:ann/target/9c8b2d587ead3afb24ec65305856912c6c46b549 covid:ann/target/c1b85cc172a5105433405983a1b9996eb7e1ee0a covid:ann/target/af96ab724822eb1da602707a2c119dd79f5521d7 covid:ann/target/2c4c65b30359d58af2164bf45c3a6aca8997cf90 covid:ann/target/27860c96577beab904eaafc6d9d24f8786faaa9c covid:ann/target/5466c8e19b05da54ee844e7f274a85c4bacdc260 covid:ann/target/1d25f95dea17ac348ca5df5f45e1999b3b1f215a covid:ann/target/3d998a832533ab6d1a5f8998b52a4ca28d4de989 covid:ann/target/68529fd4c35319e1d8e8bb52f4c7aea37c77f87b covid:ann/target/6d02d140af4c15e3fe67091c9bef97b4d02dd86c covid:ann/target/efdebd2e8c2fd03209cf082cf52c7ad3244e8bf3 covid:ann/target/88113770686f3219d7191480cf1b8a7c38d5b890 covid:ann/target/4ea42c85bf2efb10e92acecb2da3b8cf70355b21 covid:ann/target/3386570271ff68e0161cb9932301cf14974058db covid:ann/target/0415b0021ddacdcd434bc347b9304c9b85621d0a covid:ann/target/d2936497f7f86a983e68fcf0677c6008995f7ca8 covid:ann/target/2e11240cde6b66de367fe0dbe1b7eb49fadef322 covid:ann/target/32ed671c922fb677bc6b005015ce7bbcbf017d7a covid:ann/target/61b19835c6444350fd7a32811b325d1e8f2c5550 covid:ann/target/6e97a2d3d20e5d055974259b37c23cfbd4d79e4a covid:ann/target/262f08daab35f620c0cde4bfd870c6d7116d3de5 covid:ann/target/fc629c675390ad28a39d090e90d17e09480cd89a covid:ann/target/70cb2cbfcfabc1875538ff08e080ace1aecb91c5 covid:ann/target/02471772f693aaa3ff92232cdb59d5d363254127 covid:ann/target/f3b34d36f0f1de7a9dbade8a36df71108c9dc59d covid:ann/target/20ed47615c697976340d514290920d513fe8ff37 covid:ann/target/c4c83a036c0cf90bcde965547fb54bd1a14a06de covid:ann/target/80bd3401e07f12ee84a5b48f52ee04585921da87 covid:ann/target/56808eed5414778735297e29b7be695fda2ea54e covid:ann/target/762266e9d850a07360be42f6ad2c3dfcf1cb108b covid:ann/target/7c7193854bb1e688132336c3da33c43f7caa8ebf covid:ann/target/12afeb1b4d5b5d02a7ce69793a7aadb7ae8514d6 covid:ann/target/4834f728e792095638ae14a4fd69138a51d1ec2b covid:ann/target/882f3b5668610e0c55ed9462d780f9218de9c002 covid:ann/target/b2da42b0b4b1c6d6276b809d3987ab0ecb14059b covid:ann/target/4f5ff36f4f90d1a23dfd326ab7e71fec50e736a1 covid:ann/target/c2f5f53fb04e6d1e7af7baf919ff545dbac5c37b
is resource representing a document's title of	Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software